A novel onco-miR-365 induces cutaneous squamous cell carcinoma

Carcinogenesis

Volumn 34, Issue 7, 2013, Pages 1653-1659

  Zhou, Meijuan ^a   Liu, Weilin ^a   Ma, Shudong ^b   Cao, Hong ^a   Peng, Xuebiao ^b   Guo, Ling ^a,c   Zhou, Xinhua ^b   Zheng, Li ^a   Guo, Linlang ^d   Wan, Miaojian ^e   Shi, Weimin ^f   He, Yingjie ^a,g   Lu, Chao ^a   Jiang, Lihong ^a   Ou, Chengshan ^a   Guo, Yuanxia ^a   Ding, Zhenhua ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b FIRST MILITARY MEDICAL UNIVERSITY   (China)

^c TSINGHUA UNIVERSITY   (China)

^d SOUTHERN MEDICAL UNIVERSITY   (China)

^e THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^f GUANGDONG SECOND PROVINCIAL GENERAL HOSPITAL   (China)

^g Chongqing CDC ^*  (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTAGOMIR; MICRORNA; MICRORNA 365; OLIGONUCLEOTIDE; ONCOPROTEIN; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL; CARCINOGENESIS; CARCINOGENICITY; CONTROLLED STUDY; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE METASTASIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CARCINOMA; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; FEMALE; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; NEOPLASM TRANSPLANTATION; OLIGORIBONUCLEOTIDES, ANTISENSE; RNA, NEOPLASM; SKIN NEOPLASMS;

EID: 84880279377     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt097     Document Type: Article

References (33)

1. Esquela-Kerscher, A. et al. (2006) Oncomirs-microRNAs with a role in cancer. Nat. Rev. Cancer, 6, 259-269.
2. Kent, O.A. et al. (2006) Small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene, 25, 6188-6196.
3. Zhang, B. et al. (2006) MicroRNAs as oncogenes and tumor suppressors. Dev. Biol., 302, 1-12.
4. Calin, G.A. et al. (2004) MicroRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl Acad. Sci. U.S.A., 101, 2999-3004.
5. Jiang, S. et al. (2010) MicroRNA-155 functions as an oncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res., 70, 3119-3127.
6. Siomi, M.C. et al. (2011) PIWI-interacting small RNAs: the vanguard of genome defence. Nat. Rev. Mol. Cell Biol., 12, 246-258.
7. He, L. et al. (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet., 5, 522-531.
8. Zhao, Y. et al. (2007) A developmental view of microRNA function. Trends Biochem. Sci., 32, 189-197.
9. Felli, N. et al. (2005) MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc. Natl Acad. Sci. U.S.A., 102, 18081-18086.
10. He, L. et al. (2007) MicroRNAs join the p53 network-another piece in the tumour-suppression puzzle. Nat. Rev. Cancer, 7, 819-822.
11. Volinia, S. et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl Acad. Sci. U.S.A., 103, 2257-2261.
12. Iorio, M.V. et al. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res., 65, 7065-7070.
13. Eis, P.S. et al. (2005) Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc. Natl Acad. Sci. U.S.A., 102, 3627-3632.
14. John, B. et al. (2004) Human microRNA targets. PLoS Biol., 2, e363.
15. Takamizawa, J. et al. (2004) Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res., 64, 3753-3756.
16. Medina, P.P. et al. (2010) OncomiR addiction in an in vivo model of micro- RNA-21-induced pre-B-cell lymphoma. Nature, 467, 86-90.
17. Krützfeldt, J. et al. (2005) Silencing of microRNAs in vivo with 'antagomirs'. Nature, 438, 685-689.
18. Yan, L. et al. (2008) MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA, 14, 2348-2360.
19. Xu, Z. et al. (2011) MiR-365, a novel negative regulator of interleukin-6 gene expression, is cooperatively regulated by Sp1 and NF-kappaB. J. Biol. Chem., 286, 21401-21412.
20. Guo, L. et al. (2009) Differential expression profiles of microRNAs in NIH3T3 cells in response to UVB irradiation. Photochem. Photobiol., 85, 765-773.
21. Ding, Z. et al. (2002) Induction of apoptosis by the anticancer drug XK469 in human ovarian cancer cell lines. Oncogene, 21, 4530-4538.
22. Fontana, L. et al. (2008) Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM. PLoS ONE, 3, e2236.
23. Guo, H. et al. (2011) MicroRNAs-372/373 promote the expression of hepatitis B virus through the targeting of nuclear factor I/B. Hepatology, 54, 808-819.
24. Nie, J. et al. (2012) MicroRNA-365, down-regulated in colon cancer, inhibits cell cycle progression and promotes apoptosis of colon cancer cells by probably targeting cyclin D1 and Bcl-2. Carcinogenesis, 33, 220-225.
25. Qin, B. et al. (2011) MicroRNAs expression in ox-LDL treated HUVECs: miR-365 modulates apoptosis and Bcl-2 expression. Biochem. Biophys. Res. Commun., 410, 127-133.
26. Papetti, M. et al. (2011) Mybl2, downregulated during colon epithelial cell maturation, is suppressed by miR-365. Am. J. Physiol. Gastrointest. Liver Physiol., 301, G508-G518.
27. Gronostajski, R.M. (2000) Roles of the NFI/CTF gene family in transcription and development. Gene, 249, 31-45.
28. Hsu, Y.C. et al. (2011) Mesenchymal nuclear factor I B regulates cell proliferation and epithelial differentiation during lung maturation. Dev. Biol., 354, 242-252.
29. Persson, M. et al. (2009) Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc. Natl Acad. Sci. U.S.A., 106, 18740-18744.
30. Fujita, S. et al. (2008) MiR-21 gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism. J. Mol. Biol., 378, 492-504.
31. Qi, J. et al. (2012) MiR-365 regulates lung cancer and developmental gene thyroid transcription factor 1. Cell Cycle, 11, 177-186.
32. Korkmaz, G. et al. (2012) MiR-376b controls starvation and mTOR inhibition- related autophagy by targeting ATG4C and BECN1. Autophagy, 8, 165-176.
33. Shu, M. et al. (2011) MicroRNA 335 is required for differentiation of malignant glioma cells induced by activation of cAMP/protein kinase A pathway. Mol. Pharmacol., 81, 292-298.